UNLIMITED TURBO LONG - ROCHE GS Share Price

Certificat

ROGXBP

CH0334553705

Market Closed - Swiss Exchange 08:50:00 15/05/2024 pm IST
0.42 CHF +16.67% Intraday chart for UNLIMITED TURBO LONG - ROCHE GS
Current month+40.00%
1 month+5.00%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
15/24/15 0.42 +16.67%
14/24/14 0.36 -14.29%
13/24/13 0.42 +10.53%
10/24/10 0.38 +22.58%
07/24/07 0.31 +19.23%

Delayed Quote Swiss Exchange

Last update May 15, 2024 at 08:50 pm IST

More quotes

Static data

Product typeKnock-Out without Stop Loss
Buy / SellCALL
Underlying ROCHE HOLDING AG
IssuerLogo Issuer BNP Paribas BNP Paribas
ROGXBP
ISINCH0334553705
Date issued 12/08/2016
Strike 208.7 CHF
Maturity Unlimited
Parity 50 : 1
Emission price 1.05 CHF
Emission volume N/A
Settlement cash
Currency CHF

Technical Indicators

Highest since issue 4.04 CHF
Lowest since issue 0.17 CHF
Spread 0.01 CHF
Spread %2.33%

Company Profile

Roche Holding AG (Roche) is a research-based healthcare company. The Company's operating businesses are organized into two divisions: Pharmaceuticals and Diagnostics. The Pharmaceuticals Division consists of two business segments: Roche Pharmaceuticals and Chugai. The Diagnostics Division consists of four business areas: Diabetes Care, Molecular Diagnostics, Professional Diagnostics and Tissue Diagnostics. The Company develops medicines for various disease areas, including oncology, immunology, infectious diseases, ophthalmology and neuroscience. Its pharmaceutical products include Anaprox, Avastin, Bactrim, Bondronat, CellCept, Cotellic, Dilatrend, Dormicum, Invirase, Kadcyla, Kytril (Kevatril), Lariam, MabThera, Madopar, Neupogen, Pegasys, Perjeta, Pulmozyme, Rocaltrol, Rocephin and Roferon-A. The Company offers products for researchers, including cell analysis, gene expression, genome sequencing and nucleic acid purification.
Sector
-
More about the company

Ratings for Roche Holding AG

Trading Rating
Investor Rating
ESG Refinitiv
A+
More Ratings

Consensus: Roche Holding AG

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
19
Last Close Price
224.6 CHF
Average target price
279.4 CHF
Spread / Average Target
+24.39%
Consensus
  1. Stock Market
  2. Certificates
  3. ROGXBP Certificat
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW